Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05037_nanopub.RArFeOS9zATNI1mS9LtOyeg1bHVd6ZHD4o3XTQZyhaqh4#assertion>. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05037 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05037 label "AT7519 [drugbank:DB05037]" assertion.
- drugbank:DB05037 seeAlso DB05037 assertion.
- drugbank:DB05037 description "AT7519 is a selective inhibitor of certain Cyclin Dependent Kinases (CDKs) leading to tumour regression. It is developed by Astex for the treatment of solid tumours and haematological malignancies." assertion.
- drugbank:DB05037 identifier "drugbank:DB05037" assertion.
- drugbank:DB05037 title "AT7519" assertion.
- drugbank:DB05037 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05037 drugbank_vocabulary:drugbank-id "DB05037" assertion.
- drugbank:DB05037 bio2rdf_vocabulary:x-identifiers.org DB05037 assertion.
- drugbank:DB05037 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05037" assertion.
- drugbank:DB05037 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05037 bio2rdf_vocabulary:identifier "DB05037" assertion.